Replies to post #337118 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Here's what Schwab says.

As suggested by Tom, I clicked on the "B" icon on my Schwab account, and got this:

If RCB (Regulatory Circuit Breaker) displays next to the Action field in the trade tab, the Reg SHO regulatory circuit breaker is in effect for the stock. The Securities and Exchange Commission (SEC) has adopted amendments to Regulation SHO (Reg SHO). Under Rule 201, the SEC has established a short sale-related circuit breaker that, if triggered, will impose a restriction on when and/or at what price a security may be sold short.

The short sale-related circuit breaker will be triggered for a security when its price declines by 10% or more from the prior day’s closing value within normal market hours. The regulatory circuit breaker will then remain in effect for the remainder of the day, and at a minimum, throughout the next day’s trading session. The circuit breaker will be triggered during the regular session only. Once triggered, the price test will apply at all times when the national best bid is disseminated through the end of the next trading day.

When the regulatory circuit breaker rule is in force, short sale orders will continue to be accepted. However, marketable limit orders and market orders to sell short may be delayed and executed at a significantly lower price than the bid at the time the order was placed.

Tomorrow, I'll sit back and watch AVXL trading action, whatever it might be (if any). Not much about AVXL shares is typical or normal. Neither is the company itself. Its technology is different altogether. Will change 21st century medical practice in a few years.